Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2023-12-01
2024-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* the efficacy of the two devices in the reduction of the overjet
* the neuromuscolar effects developed on the stomatognatic system Participants will be instructed in the use and maintenance of the devices and will be checked every 15-30 days for one year.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Removable Devices in Palatal Expansion
NCT05848882
Morphological Changes of Removable Orthodontic Retainers During the Use
NCT06283823
Interceptive Maxillary Expansion to Relief Anterior Crowding in the Mixed Dentition
NCT06187337
Comparison Between Mini Implant Supported Appliance and Headgear in Treatment of Maxillary Excess in Growing Patients
NCT03839303
The Efficacy of Tow Mechanics for Total-maxillary-arch-distalization
NCT04814173
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Elastodontic removable device
Patients in this group will be treat with an elastodontic device adapted to the patient according to the shape of the dental arches. This device is similar to a mouthguard and embraces both dental arches. This appliance is worn overnight and the patient will be checked every month. The degree of will be taken at T0( before the start of the therapy), at T1 (after six months)and at T2 (after one month). All the dental recors will be taken by the same operator with an intraoral scanner 3D.
dental movement
Possibility to reduce the protrusion of upper incisors
Clear Aligners
Patients in this group will be treat with clear aligners of the dental arches. This removable device Is transparent and covers all tooth surfaces perfectly. This appliance is 22 hours at day and the patient will be checked every month. The degree of will be taken at T0( before the start of the therapy), at T1 (after six months)and at T2 (after one month). All the dental records will be taken by the same operator with an intraoral scanner 3D.
dental movement
Possibility to reduce the protrusion of upper incisors
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dental movement
Possibility to reduce the protrusion of upper incisors
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* complete eruption of upper first premolars
* presence of unilateral or bilateral cross bite (falling within grade 3 IOTN index).
Exclusion Criteria
* presence of epilepsy,
* systemic disease,
* TMD, or periodontal disease;
* lack of written informed consent from a parent or legal guardian.
9 Years
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of L'Aquila
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eleonora Ortu
Researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dipartimento MESVA
L’Aquila, Italia, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB L'Aquila 02/2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.